• Paul B McBeth, Jordan A Weinberg, Babak Sarani, Louise Y Y Yeung, and Addison K May.
• Departments of Surgery and Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.
• Trauma Surg Acute Care Open. 2016 Jan 1; 1 (1): e000020.

AbstractAn increasing number of potent antiplatelet and anticoagulant medications are being used for the long-term management of cardiac, cerebrovascular, and peripheral vascular conditions. Management of these medications in the perioperative and peri-injury settings can be challenging for surgeons, mandating an understanding of these agents and the risks and benefits of various management strategies. In this two-part review, agents commonly encounter by surgeons in the perioperative and peri-injury settings are discussed and management strategies for patients on long-term antiplatelet and anticoagulant therapy reviewed. In part I, we review warfarin and the new direct oral anticoagulants. In part II, we review antiplatelet agents and assessment of platelet function and the perioperative management of long-term anticoagulant and antiplatelet therapy.

2 keywords...

hide…